Abstract

BackgroundAdoptive transfer of autologous T cells derived from tumor fragments cultured in IL-2 have been successful in treating melanomas and select epithelial cancers.1 2 However, tumor-reactive T cells are a...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call